Par Pharmaceutical Holding IPO Research Information

Par Pharmaceutical Holding IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Par Pharmaceutical Holding, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Par Pharmaceutical Holding	PRX - NYSE	Withdrawn	$0.00	$0.00	Withdrawn
Underwriter(s): J.P Morgan, Goldman Sachs & Co.
Co-Manager(s): Citigroup, Morgan Stanley,BofA Merrill Lynch, Deutsche Bank Securities, Evercore ISI, RBC Capital Markets, TPG Capital BD, LLC, BMO Capital Markets, Mizuho
Industry:
Filing(s): Filed 2015-03-13

About Par Pharmaceutical Holding (adapted from Par Pharmaceutical Holding prospectus):
They are a leading U.S. pharmaceutical company specializing in developing, licensing, manufacturing, marketing and distributing generic drugs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "PRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.